| The companies announced they plan to file Friday for regulatory approval of their coronavirus vaccine, a landmark moment and a signal that a powerful tool to help control the pandemic could begin to be available within weeks. Once the companies file their application, those findings will be scrutinized by regulators, potentially paving the way for limited doses of the vaccine to be available in December. | 
No comments:
Post a Comment